| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,176 |
14,315 |
$1.22M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,713 |
7,996 |
$494K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
12,045 |
11,314 |
$484K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,319 |
3,883 |
$330K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,271 |
3,196 |
$262K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,593 |
2,511 |
$211K |
| 90461 |
|
6,065 |
5,790 |
$165K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
703 |
681 |
$61K |
| 99215 |
Prolong outpt/office vis |
447 |
427 |
$45K |
| 99381 |
|
508 |
502 |
$45K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
328 |
319 |
$36K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,874 |
1,435 |
$27K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,549 |
1,485 |
$23K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,017 |
1,005 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
295 |
279 |
$14K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
860 |
823 |
$9K |
| 0071A |
|
139 |
115 |
$9K |
| 0072A |
|
122 |
100 |
$8K |
| 99383 |
|
44 |
44 |
$4K |
| 99173 |
|
3,226 |
2,977 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
106 |
104 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
198 |
185 |
$3K |
| 0081A |
|
36 |
36 |
$3K |
| 85014 |
|
830 |
802 |
$2K |
| 96127 |
|
437 |
436 |
$2K |
| 99401 |
|
91 |
87 |
$2K |
| 81000 |
|
547 |
493 |
$2K |
| 90686 |
|
932 |
853 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
90 |
77 |
$2K |
| 0082A |
|
18 |
18 |
$1K |
| 90480 |
|
57 |
48 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
55 |
53 |
$886.39 |
| 99201 |
|
18 |
17 |
$469.51 |
| 99050 |
|
87 |
86 |
$409.06 |
| 96380 |
|
12 |
12 |
$255.96 |
| 90688 |
|
471 |
425 |
$115.41 |
| 90670 |
|
1,324 |
1,249 |
$64.95 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
150 |
134 |
$57.20 |
| 94760 |
|
54 |
53 |
$34.84 |
| 90672 |
|
31 |
27 |
$21.46 |
| 90707 |
|
611 |
556 |
$10.82 |
| 90716 |
|
610 |
564 |
$10.82 |
| 90680 |
|
1,152 |
1,083 |
$5.19 |
| 90648 |
|
1,114 |
1,048 |
$4.48 |
| 90633 |
|
679 |
654 |
$1.49 |
| 90700 |
|
160 |
160 |
$0.00 |
| 99446 |
|
46 |
42 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
16 |
14 |
$0.00 |
| 90671 |
|
356 |
344 |
$0.00 |
| 90685 |
|
277 |
268 |
$0.00 |
| 90710 |
|
99 |
97 |
$0.00 |
| 90734 |
|
86 |
80 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
13 |
13 |
$0.00 |
| 90715 |
|
17 |
13 |
$0.00 |
| 91307 |
|
61 |
48 |
$0.00 |
| 90698 |
|
240 |
238 |
$0.00 |
| 90723 |
|
718 |
663 |
$0.00 |
| 90656 |
|
257 |
255 |
$0.00 |
| 90696 |
|
164 |
143 |
$0.00 |
| 90651 |
|
179 |
168 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
13 |
13 |
$0.00 |